Anmol Baranwal - Concepedia

Author

Anmol Baranwal

Mayo Clinic in Arizona ORCID

Also Known As

A. Baranwal, Anmol Baranwal, Baranwal A

Publications

430

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona Central Adelaide Local Health Network Royal Adelaide Hospital Mayo Clinic South Australian Health and Medical Research Institute

About

Anmol Baranwal is an author at Mayo Clinic in Arizona specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	246
2	Health Sciences	2	2	197
3	Immunology	2	2	34
4	Cell Biology	1	1	36
5	Genetic Medicine	1	1	36

Anmol Baranwal

Publications

308

Citations

H-Index

Page 1

	Year	Citations
Platelet functional defects in women with unexplained menorrhagia Claire S. Philipp, Anne Dilley, Connie H. Miller, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisPlatelet Functional DefectsBlood PlateletHematology	2003	161
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms Mithun Vinod Shah, Elizabeth Ngoc Hoa Tran, Syed Shah, Blood Cancer Journal	2023	40
<i>TP53</i>mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype Devendra Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Blood ImmunohematologyCancer PathologyPathologyGenetic MedicineTumor Biology	2022	36
Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy Mark E. Gurney, Anmol Baranwal, Allison Rosenthal, JAMA Oncology Hematological MalignancyLymphoid NeoplasiaCancer ImmunosurveillanceMyeloid NeoplasmsMedicine	2024	21
Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study Anmol Baranwal, Rakchha Chhetri, David T Yeung, Bone Marrow Transplantation Therapy-related AmlDisease ProgressionMedicinePrognosisMulticenter Study	2023	15
Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms Mithun Vinod Shah, Rakchha Chhetri, Ruchita Dholakia, American Journal of Hematology Hematological MalignancyTherapy‐related Myeloid NeoplasmsAcute Myeloid LeukemiaMedicineHematology	2022	13
Evidence-based risk stratification of myeloid neoplasms harboring <i>TP53</i> mutations Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Blood Advances	2025	12
Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring <i>TP53</i> mutations Anmol Baranwal, Kimberly J. Langer, Vedavyas Gannamani, Blood Advances	2025	10

Page 1